LARP1 is under increasing scrutiny because of its clinical significance: in addition to contributions to the progression of some cancers (Mura et al., 2015) and a possible link to Zika virus pathogenesis (Scaturro et al., 2018), LARP1 was recently found to physically associate with the RNA-binding nucleocapsid of the recently-emerged zoonotic coronavirus SARS-CoV-2 (Gordon et al., 2020). Here, LARP1 is linked to cancer.